These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1539513)
1. The effect of ergonovine on coronary vasodilatory reserve in patients with angiographically normal coronary arteries. Tatineni S; Kern MJ; Aguirre F Am Heart J; 1992 Mar; 123(3):617-20. PubMed ID: 1539513 [TBL] [Abstract][Full Text] [Related]
2. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Cannon RO; Schenke WH; Leon MB; Rosing DR; Urqhart J; Epstein SE Circulation; 1987 Jan; 75(1):163-74. PubMed ID: 3791602 [TBL] [Abstract][Full Text] [Related]
3. Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina. Akasaka T; Yoshida K; Hozumi T; Takagi T; Kawamoto T; Kaji S; Morioka S; Yoshikawa J Am J Cardiol; 1997 Sep; 80(6):705-10. PubMed ID: 9315573 [TBL] [Abstract][Full Text] [Related]
4. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound. Sudhir K; MacGregor JS; Barbant SD; Foster E; Fitzgerald PJ; Chatterjee K; Yock PG J Am Coll Cardiol; 1993 Apr; 21(5):1261-8. PubMed ID: 8459086 [TBL] [Abstract][Full Text] [Related]
5. Experience with ergonovine provocative testing for coronary arterial spasm. Magder SA; Johnstone DE; Huckell VF; Adelman AG Chest; 1981 Jun; 79(6):638-46. PubMed ID: 6785015 [TBL] [Abstract][Full Text] [Related]
6. Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries. Cannon RO; Cattau EL; Yakshe PN; Maher K; Schenke WH; Benjamin SB; Epstein SE Am J Med; 1990 Mar; 88(3):217-22. PubMed ID: 2309738 [TBL] [Abstract][Full Text] [Related]
7. Chest pain and "normal" coronary arteries--role of small coronary arteries. Cannon RO; Leon MB; Watson RM; Rosing DR; Epstein SE Am J Cardiol; 1985 Jan; 55(3):50B-60B. PubMed ID: 3969858 [TBL] [Abstract][Full Text] [Related]
8. Different responses of coronary artery and internal mammary artery bypass grafts to ergonovine and nitroglycerin in variant angina. Kitamura S; Morita R; Kawachi K; Iioka S; Seki T; Inoue K; Taniguchi S Ann Thorac Surg; 1989 May; 47(5):756-60. PubMed ID: 2499280 [TBL] [Abstract][Full Text] [Related]
9. Vasomotor response to ergonovine of epicardial and resistance coronary arteries in the nonspastic vascular bed in patients with vasospastic angina. Nakamura Y; Yamaguro T; Inoki I; Takemori H; Katsuki T; Takata S; Kobayashi K Am J Cardiol; 1994 Nov; 74(10):1006-10. PubMed ID: 7977037 [TBL] [Abstract][Full Text] [Related]
10. Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation and coronary artery disease. Kern MJ; Bach RG; Mechem CJ; Caracciolo EA; Aguirre FV; Miller LW; Donohue TJ J Am Coll Cardiol; 1996 Nov; 28(5):1154-60. PubMed ID: 8890809 [TBL] [Abstract][Full Text] [Related]
11. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Crossman DC; Larkin SW; Fuller RW; Davies GJ; Maseri A Circulation; 1989 Sep; 80(3):475-84. PubMed ID: 2475277 [TBL] [Abstract][Full Text] [Related]
12. Quantitative arteriographic responses to ergonovine provocation in subjects with atypical chest pain. Kimball BP; LiPreti V; Aldridge HE Am J Cardiol; 1989 Oct; 64(12):778-82. PubMed ID: 2801529 [TBL] [Abstract][Full Text] [Related]
13. Coronary hemodynamic effects of ergonovine maleate in human subjects. Orlock AE; Ricci DR; Cipriano PR; Guthaner DF; Harrison DC Am J Cardiol; 1980 Jan; 45(1):48-52. PubMed ID: 7350773 [TBL] [Abstract][Full Text] [Related]
14. Limitations of ergonovine testing in patients with variant angina. Mautner RK; Iteld B; Giles TD Cathet Cardiovasc Diagn; 1982; 8(4):357-62. PubMed ID: 7127460 [TBL] [Abstract][Full Text] [Related]
15. Comparison of coronary responses to intracoronary and intraaortic ergonovine and isosorbide dinitrate in patients with atypical chest pain. Hoshio A; Shirota K; Sawada Y; Fukuki M; Doi T; Kotake H; Mashiba H; Kasahara T; Endo S Am J Cardiol; 1992 Oct; 70(11):1004-9. PubMed ID: 1414896 [TBL] [Abstract][Full Text] [Related]
16. Coronary reactivity to ergonovine--possible relationship to accelerated coronary arterial disease in cardiac transplant recipients. Kushwaha S; Lythall D; Maseri A; Mitchell A; Yacoub M Eur Heart J; 1991 Apr; 12(4):520-5. PubMed ID: 2065686 [TBL] [Abstract][Full Text] [Related]
17. Variability in coronary hemodynamics in response to ergonovine in patients with normal coronary arteries and atypical chest pain. Schwartz AB; Donmichael TA; Botvinick EH; Ishimori T; Parmley WW; Chatterjee K J Am Coll Cardiol; 1983 Mar; 1(3):797-803. PubMed ID: 6826971 [TBL] [Abstract][Full Text] [Related]
18. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve. Sonoda S; Takeuchi M; Nakashima Y; Kuroiwa A Am Heart J; 1998 Apr; 135(4):621-7. PubMed ID: 9539477 [TBL] [Abstract][Full Text] [Related]
19. Effect of intracoronary adenosine on ergonovine-induced vasoconstricted coronary arteries. Oh JH; Song S; Kim C; Ahn J; Park JS; Lee HW; Choi JH; Lee HC; Cha KS; Hong TJ Cardiol J; 2019; 26(6):653-660. PubMed ID: 30009375 [TBL] [Abstract][Full Text] [Related]
20. Biphasic response of coronary arterial diameter to intracoronary ergonovine. Mohri M; Okamatsu S; Nakamura M Clin Cardiol; 1988 Oct; 11(10):710-4. PubMed ID: 3224455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]